Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
Sponsor: Ying Liu
Summary
The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.
Official title: The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2019-09-30
Completion Date
2026-12
Last Updated
2026-04-09
Healthy Volunteers
Yes
Interventions
Ropivacaine Infusion from ON-Q Pump
Infusion of 0.2% ropivacaine at 8 mL/hour for 72 hours
Ropivacaine + Ketorolac Infusion from ON-Q Pump
Infusion of 0.2% ropivacaine + 30 mg ketorolac at 8 mL/hour for 72 hours
Normal Saline Infusion from ON-Q Pump
Infusion of 0.9% normal saline at 8 mL/hour for 72 hours
Locations (2)
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
The GW Medical Faculty Associates
Washington D.C., District of Columbia, United States